Halozyme Therapeutics Inc (HALO)
45.73
-0.03
(-0.07%)
USD |
NASDAQ |
Nov 21, 16:00
45.82
+0.09
(+0.20%)
After-Hours: 17:30
Halozyme Therapeutics Market Cap: 5.818B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 5.822B |
| November 19, 2024 | 5.701B |
| November 18, 2024 | 5.416B |
| November 15, 2024 | 5.808B |
| November 14, 2024 | 6.865B |
| November 13, 2024 | 7.457B |
| November 12, 2024 | 7.584B |
| November 11, 2024 | 7.772B |
| November 08, 2024 | 7.758B |
| November 07, 2024 | 7.589B |
| November 06, 2024 | 7.714B |
| November 05, 2024 | 7.471B |
| November 04, 2024 | 7.439B |
| November 01, 2024 | 7.271B |
| October 31, 2024 | 6.434B |
| October 30, 2024 | 6.436B |
| October 29, 2024 | 6.443B |
| October 28, 2024 | 6.420B |
| October 25, 2024 | 6.266B |
| October 24, 2024 | 6.272B |
| October 23, 2024 | 6.461B |
| October 22, 2024 | 6.556B |
| October 21, 2024 | 6.584B |
| October 18, 2024 | 6.691B |
| October 17, 2024 | 6.649B |
| Date | Value |
|---|---|
| October 16, 2024 | 6.799B |
| October 15, 2024 | 6.845B |
| October 14, 2024 | 6.862B |
| October 11, 2024 | 6.741B |
| October 10, 2024 | 6.630B |
| October 09, 2024 | 6.443B |
| October 08, 2024 | 6.884B |
| October 07, 2024 | 6.849B |
| October 04, 2024 | 7.527B |
| October 03, 2024 | 7.686B |
| October 02, 2024 | 7.397B |
| October 01, 2024 | 7.204B |
| September 30, 2024 | 7.280B |
| September 27, 2024 | 7.217B |
| September 26, 2024 | 7.214B |
| September 25, 2024 | 7.078B |
| September 24, 2024 | 7.119B |
| September 23, 2024 | 7.414B |
| September 20, 2024 | 7.504B |
| September 19, 2024 | 7.537B |
| September 18, 2024 | 7.893B |
| September 17, 2024 | 7.845B |
| September 16, 2024 | 7.969B |
| September 13, 2024 | 7.892B |
| September 12, 2024 | 7.669B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.919B
Minimum
Mar 18 2020
8.161B
Maximum
Aug 28 2024
5.300B
Average
5.467B
Median
Mar 04 2021
Market Cap Benchmarks
| Abbott Laboratories | 203.38B |
| Novavax Inc | 1.289B |
| Insulet Corp | 18.38B |
| BioLife Solutions Inc | 1.178B |
| TransMedics Group Inc | 2.661B |
Market Cap Related Metrics
| PE Ratio | 15.14 |
| PS Ratio | 6.267 |
| PEG Ratio | 0.2497 |
| Price to Book Value | 12.85 |
| Price to Free Cash Flow | 15.12 |
| Price | 45.73 |
| Earnings Yield | 6.60% |
| PEGY Ratio | 0.2497 |
| Operating PE Ratio | 12.45 |
| Normalized PE Ratio | 15.87 |